NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 318 filers reported holding NATERA INC in Q3 2023. The put-call ratio across all filers is 1.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $334,388,063 | -0.6% | 7,556,792 | +9.3% | 0.04% | 0.0% |
Q2 2023 | $336,371,517 | -8.8% | 6,912,690 | +4.0% | 0.04% | -17.8% |
Q1 2023 | $368,949,776 | +147975.1% | 6,645,333 | +7.1% | 0.04% | +36.4% |
Q4 2022 | $249,164 | -99.9% | 6,202,712 | +11.4% | 0.03% | -5.7% |
Q3 2022 | $244,094,000 | +25.9% | 5,570,372 | +1.8% | 0.04% | +29.6% |
Q2 2022 | $193,955,000 | -4.8% | 5,472,779 | +9.3% | 0.03% | +8.0% |
Q1 2022 | $203,655,000 | -57.1% | 5,006,279 | -1.4% | 0.02% | -54.5% |
Q4 2021 | $474,337,000 | -9.9% | 5,079,091 | +7.5% | 0.06% | -15.4% |
Q3 2021 | $526,389,000 | +76.2% | 4,723,517 | +79.5% | 0.06% | +80.6% |
Q2 2021 | $298,712,000 | -10.5% | 2,631,131 | -19.9% | 0.04% | -20.0% |
Q1 2021 | $333,661,000 | +12.9% | 3,286,004 | +10.6% | 0.04% | +4.7% |
Q4 2020 | $295,595,000 | +31.8% | 2,970,193 | -3.8% | 0.04% | +13.2% |
Q3 2020 | $224,326,000 | +45.5% | 3,086,915 | -0.2% | 0.04% | +26.7% |
Q2 2020 | $154,206,000 | +79.5% | 3,092,809 | +7.5% | 0.03% | +50.0% |
Q1 2020 | $85,901,000 | +95.8% | 2,876,779 | +120.9% | 0.02% | +150.0% |
Q4 2019 | $43,869,000 | +2991.5% | 1,302,117 | +2910.7% | 0.01% | – |
Q3 2019 | $1,419,000 | +241.9% | 43,250 | +181.4% | 0.00% | – |
Q2 2019 | $415,000 | +134.5% | 15,369 | +79.0% | 0.00% | – |
Q1 2019 | $177,000 | -92.2% | 8,587 | -94.7% | 0.00% | -100.0% |
Q4 2018 | $2,272,000 | -40.7% | 162,755 | +1.6% | 0.00% | 0.0% |
Q3 2018 | $3,833,000 | +293.1% | 160,128 | +209.0% | 0.00% | – |
Q2 2018 | $975,000 | +1525.0% | 51,818 | +706.1% | 0.00% | – |
Q1 2018 | $60,000 | -91.3% | 6,428 | -91.6% | 0.00% | – |
Q4 2017 | $687,000 | +1045.0% | 76,379 | +1031.7% | 0.00% | – |
Q1 2017 | $60,000 | -77.0% | 6,749 | -69.7% | 0.00% | – |
Q4 2016 | $261,000 | -89.7% | 22,299 | -90.2% | 0.00% | -100.0% |
Q3 2016 | $2,539,000 | -23.8% | 228,571 | -17.2% | 0.00% | 0.0% |
Q2 2016 | $3,330,000 | +332900.0% | 276,030 | +246355.4% | 0.00% | – |
Q1 2016 | $1,000 | -99.9% | 112 | -99.9% | 0.00% | – |
Q3 2015 | $1,132,000 | – | 104,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 1,104,581 | $48,403,000 | 19.54% |
Kynam Capital Management, LP | 2,018,360 | $88,445,000 | 18.64% |
Foresite Capital Management III, LLC | 159,160 | $6,974,000 | 18.41% |
Sofinnova Investments, Inc. | 3,102,960 | $135,972,000 | 7.91% |
Eagle Health Investments LP | 595,994 | $26,116,000 | 5.99% |
Eversept Partners, LP | 1,425,602 | $62,469,880 | 5.41% |
Lagoda Investment Management, L.P. | 159,220 | $6,977,000 | 4.96% |
Hudson Executive Capital LP | 588,886 | $25,805,000 | 3.70% |
Parian Global Management LP | 24,000 | $1,052,000 | 3.42% |
BRANDYWINE MANAGERS, LLC | 21,534 | $944,000 | 3.10% |